Levitra news | Breaking Levitra news | Levitra

Manhattan Research Reveals Top Ten Consumer-Ranked Pharmaceutical ...

...Manhattan Research Products and Services In addition to ePharma Consumer(R), Manhattan Research conducts annual research studies among physicians and consumers, including Taking the Pulse(R) Europe, Cybercitizen(R) Health, ePharma Consumer(R), Taking the Pulse(R) and ePharma Physician(R).

Each study serves a unique purpose and focuses on different aspects of information technology adoption.

Broad consumer and physician research is complemented by targeted analysis among more than 30 consumer therapeutic segments and 20 physician specialist segments.

MEDIA CONTACT: Erica Alexander ealexander@manhattanresearch.com 212.255.7799 SOURCE Manhattan Research Web Site: http://www.manhattanresearch.com/epc.htmhttp://www.manhattanresearch.com Contact: Erica Alexander of Manhattan Research, +1-212-255-7799,or ealexander@manhattanresearch.com Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.Terms and conditions, including restrictions ...

Mixed feeling over Bayer results

...Importantly, the strong performance of the newly-acquired portfolio of OTC drugs helped the group largely offset - within the same year - the increase in net debt resulting from the purchase.

Although currently the world's third-largest OTC business, Wenning boldly stated that Bayer is hoping to become the leading global provider of self-medication products, but he would not be drawn to a specified date of when he expects to the group to take pole position.Commenting on Bayer's achievements for 2005, Wenning told conference attendees that the numbers "underscore the fact that our strategic alignment toward innovation and growt...

Fourth-quarter profit falls, but total Bayer sales up

...Wenning said Bayer wants to widen its health care unit and would consider making acquisitions to expand its over-the-counter drug lineup - providing that targets fit Bayer's business plan.

Wenning made the remark at a news conference when asked whether Bayer would bid for Pfizer's over-the-counter division if it were put up for sale.

Pfizer said last month it might sell or spin off the unit.

Back to headlines Today's Most-Read Articles 1.

Steelers, rest of NFL on hold again 2.

NFL labor negotiations take a new twist 3.

Arrington buys his freedom from Redskins 4.

Junker: Tracy a breath of fresh air 5.

NFL roundup: Steelers cut Stuvaints, Logan Today's Most-Sent Articles 1.

Pension reform may kill plans 2.

New line of greeting cards for inmates 3.

Embattled cleric cites ancestor's example 4.

Living with lupus 5.

Man found dead near steel cross at retreat Click here for advertising information Terms of Service Search Classifieds AutoLIVE.com Real Estate PaJobMatch.com Search Local Stores Search Newspaper Ads Buy & Sell Tickets Groce...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Sexuality   Health and Fitness   Health Living